Plunkett Research Online: Epirus Biopharmaceuticals Inc

EPIRUS BIOPHARMACEUTICALS INC (EPRSQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare diseases by improving patient access through cost-effective medicines. The product candidates of the company are BOW080 for the potential treatment of ultra-rare blood disorders.....


EPIRUS BIOPHARMACEUTICALS INC

Ticker: EPRSQ
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 600-4164
Fax:
Address: 699 Boylston Street
Boston, MA 02116 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Robert TicktinGeneral Counsel/Secretary/Senior VP
EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare diseases by improving patient access through cost-effective medicines. The product candidates of the company are BOW080 for the potential treatment of ultra-rare blood disorders.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture